About Us
iBET – Instituto de Biologia Experimental e Tecnológica is a private non-profit institution of public utility dedicated to R&D in Biotechnology.
For over 35 years, we have been creating and transferring knowledge to our global biopharma and biotech partners and to the national pharma and agri-food industry sector.
Guided by our values, we strive to achieve our vision through all aspects of our activities and the achievements they deliver.
Agility
We foster a culture of continuous improvement and embrace change as an opportunity for growth. We excel in flexibility and speed of execution of our research services.
Ambition
We are determined to achieve our goals, inspired by the creation of value for our partners, using persistence, will and restlessness.
Commitment
We are truly focused and feel responsible for our stakeholders (team, partners, and society) offering our best knowledge. Our people are our greatest asset, and we are committed to supporting their growth and career development.
Innovation
We look for novelty in each project and find solutions that add value to the institution and the client. We take the risk to create something new.
Integrity
We act with honesty and ethics. We respect our partners and all stakeholders. We use scientific and technological knowledge to create value for the market and society in general.
Search for Knowledge
We search to know more. We look for the best solutions and sharing the best practices internally and externally.
Agility
We foster a culture of continuous improvement and embrace change as an opportunity for growth. We excel in flexibility and speed of execution of our research services.
Ambition
We are determined to achieve our goals, inspired by the creation of value for our partners, using persistence, will and restlessness.
Commitment
We are truly focused and feel responsible for our stakeholders (team, partners, and society) offering our best knowledge. Our people are our greatest asset, and we are committed to supporting their growth and career development.
Innovation
We look for novelty in each project and find solutions that add value to the institution and the client. We take the risk to create something new.
Integrity
We act with honesty and ethics. We respect our partners and all stakeholders. We use scientific and technological knowledge to create value for the market and society in general.
Search for Knowledge
We search to know more. We look for the best solutions and sharing the best practices internally and externally.
Achievements
R&D projects with competitive funding, of which 59 were internationally funded
R&D Projects with Industry Partners
Technologies or Methodologies implemented with support from iBETXplore Innovation program
Peer-reviewed publications in 2023
Were added in 2023 to our infrastructure with the newly built R&D iBET Biofarma building.
BSL3 research lab
See iBET Institutional Video
Objectives in pursuit of our mission:
Foster Excellence and Economic Competitiveness
Maintain a leadership role in creating and sustaining excellence in all its teams and collaborations ensuring economic competitiveness.
Support Industry
Provide a Support Infrastructure allowing to lower investment costs for Portuguese and international companies willing to start or reinforce biotechnological research and manufacturing in Portugal.
Stimulate Technology Transfer
Push for faster utilization of new biotechnological tools in industry activities.
Develop highly skilled talent
To train multidisciplinary and creative researchers in applied research targeted to biotechnological development and technology transfer.
Support New Companies
Support start-up/spinoff companies at the incubation stage of their activities.
Team & Structure
With a staff of over 270 people, iBET currently hosts over 110 PhD holders and 40 PhD students, distributed across 14 research teams and support units.
Learn more
Institutional Information
Annual Activity Report 2023
Explore our R&D outputs and key milestones from 2023, including financial and operational KPIs.
Download pdf
Statutes
iBET’s statutes provide a deeper understanding of our organization’s structure and governance. [Portuguese only]
Download pdf
Gender Equality Policy
iBET’s Gender Equality and Inclusion plan specifies measures to promote a gender balance across all functional levels and the non-discrimination of employees by any social, racial, cultural or gender related aspects.
Download pdf
Shareholders & Equity
iBET’s shareholders have privileged access to our scientific expertise in biotechnology.
Learn more
- 1989
- 1990
- 1991
- 1993
- 1994
- 1997
- 2000
- 2001
- 2003
- 2004
- 2006
- 2009
- 2011
- 2012
- 2013
- 2015
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
Establishment of collaboration with GBF (Gesellschaft fur Biotechnologische Forschung, today HZI)
Pilot Plant Project – German Ministry of S&T grants 2 million marcs for support, training and education
Good Laboratory Practices (GLP) Infrastructure initiates activity with German HOECHST
Start of Activities with the German SCHERING (protein structures)
- Inauguration of the Pilot Plant Facility by Official Entities
- Animal Cell Technology and Microbiology Labs move to the New Building
- Establishment of Plant Biotechnology Network with SOPORCEL and PORTUCEL FLORESTAL
- Start collaboration with MERCK in Cancer Therapy
Submission of patents: four national, two European and one international (PCT)
Establishment of Oeiras Associate Laboratory: iBET, ITQB and Instituto Gulbenkian de Ciência
Encapsulated adenovirus developed at iBET moves to veterinary field trials in three African countries.
Retroviral Vectors developed at the Animal Cell Technology Laboratory and GENETHON move to gene therapy clinical trial in France.
- Establishment of the CLINIGENE International Network of Excellence in Gene and Cell Therapy. iBET is partner and member of the board.
- Signature of the collaboration agreement between iBET- MERCK which opened the door for the creation of a new satellite laboratory.
- GeniBET, a spin-off dedicated to producing biopharmaceuticals for phase I/II clinical trials was created.
BAYER Satellite laboratory contract signature (node of Bayer R&D)
Starting of project with ASTRAZENECA, BAYER and ROCHE under the scope of Innovative Medicines Initiative (IMI) – cancer models
- Development of in vitro cellular models for neuropharmacology with TECNIMEDE
- Researchers from the Animal Cell Technology Unit reproduce cellular models of human livers
The Analytical Services Unit is GMP certified by INFARMED (the Portuguese Medicines Authority) and by DGAV (the Portuguese veterinary Authority)
- NOVARTIS Satellite Laboratory contract signature
- The iNOVA4Health Programme, of which iBET is a partner and coordinator, is set up for a new paradigm of Personalized Medicine and Healthy Aging
iBETXplore internal funding program is launched to support innovative ideas by iBET researchers
Sanofi Satellite Laboratory contract is signed, marking the start of iBET’s fourth satellite laboratory with international biopharma companies.
- Inauguration of “Late-Stage R&D and Bioproduction Unit”
- iBET celebrates its 30th anniversary.
iBET launches the initiative Serology for COVID together with partner institutes of the Lisbon area and its partner Medinfar to develop serologic tests for COVID-19.
The construction of the new iBET Biofarma building starts.
- GenIbet acquired by Swedish CDMO RECIPHARM
- Kick-off of the new Associate Laboratory LS4Future, with partner institutes ITQB NOVA, Instituto Gulbenkian de Ciência, NOVA Medica School and IPO Lisbon.
- Inauguration and phased occupation of iBET Biofarma building has allowed expanding our R&D infrastructure over a total area of 6700m2 with an investment of more than 25M euros.
- Launch of the new Translational Immunology Lab